Relapse rate of vivax malaria with shorter duration of antirelapse treatment in Iran

AUTHORS

Masoud Salehi 1 , * , M Esmaeil Zadeh 2

1 Tropical and Infectious diseases dept, faculty of medicine, Zahedan university of medical sciences and health services, Zahedan, Iran.

2 Specialist in Tropical and Infectious diseases.

How to Cite: Salehi M, Esmaeil Zadeh M. Relapse rate of vivax malaria with shorter duration of antirelapse treatment in Iran, Zahedan J Res Med Sci. 2002 ; 4(2):e95335.

ARTICLE INFORMATION

Zahedan Journal of Research in Medical Sciences: 4 (2); e95335
Published Online: June 05, 2002
Article Type: Research Article
Received: April 01, 2002
Accepted: April 30, 2002
READ FULL TEXT

Abstract

Every year thousand of malaria cases mostly the vivax type Occur in Iran. The
recommendation of WHO for antirelapes therapy of vivax malaria is the usage of primaquine
(15mg daily) for 14 days but in area where G6PD deficiency rate is high 8 weeks therapy
(each week 45 mg of primaquine) is recommended. Considering the fact that in Iran drug
therapy of malaria is implemented by direct observation of health care workers, 8 weeks
regime of antirelapes therapy of vivax is very expensive and in some situations impractical. In
this study shorter duration of antirelapse therapy was compared to that of 8 weeks regimen.
In 1996 and 1997 antirelapse therapy of vivax in Sistan and Baluchistan province in
southeast of Iran was done with different regimes according to manpower and executive
facilities. This is a cohort study that compare clinically and parasitologicaly relapse of vivax
malaria in 200 patients with one-week therapy, 200 patients with 2 weeks, 800 patients with 4
weeks and 500 patients with 8 weeks therapy by primaquine.
Relapes rate of vivax malaria by each regiem were 23.8%,13.2%,5.4% and 4.6% respectively
.Relative risk of relapse in comparison with 8 weeks regiem were 5.2 ,2.9 and 1.2 respectively
.Number need to therapy (NNT) were 5,12 and 125 .Interval of first relapse varied between 6
to 52 weeks with mean of 28.8 weeks . The relapse rate was not different by sex.
The relapse rate by 4 and 8 weeks regimes were low and there was not significant difference
of relapse rate in 4 and 8 weeks regimes. So in special situations we can use 4 weeks therapy
instead of 8 weeks therapy.

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.

    The References of this article are available on the PDF file.

  • © 2002, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: